Evaluating muscle loss and surgical outcomes in colorectal cancer patients
Prevalence of Preoperative Sarcopenia and Its Impact on Surgical Outcomes in Patients With Colorectal Cancer: A Prospective Study
This study is trying to see if losing muscle before surgery affects recovery and complications in people with colorectal cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 64 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mersin University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Mersin) |
| Trial ID | NCT06698289 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the prevalence of preoperative sarcopenia in patients diagnosed with colorectal cancer and its impact on postoperative outcomes. By utilizing validated methods to evaluate muscle strength, quantity, and physical performance, the study seeks to establish a correlation between sarcopenia and adverse surgical outcomes such as complications and prolonged hospital stays. The findings will provide valuable prognostic information for both surgeons and patients, emphasizing the importance of early screening and management of sarcopenia in colorectal cancer treatment.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with colon cancer and are scheduled for surgery at Mersin University.
Not a fit: Patients under 18 years of age or those without recorded clinical characteristics will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and quality of life for colorectal cancer patients by addressing sarcopenia.
How similar studies have performed: While the prevalence of sarcopenia in colorectal cancer has been noted in previous studies, this specific approach to evaluating its impact on surgical outcomes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Having a diagnosis of colon cancer * Having undergone surgery at Mersin University General Surgery Department as of 15.11.2024 * Patients aged 18 years and above * Patients whose descriptive and clinical characteristics are recorded in their medical files * Those who have signed the Informed Volunteer Consent Form/Written Consent Form Exclusion Criteria: * Patients under 18 years of age * Patients whose descriptive and clinical characteristics are not recorded in the file records * Those who did not sign the Informed Volunteer Form/Written Consent Form
Where this trial is running
Mersin
- Mersin University — Mersin, Turkey (Recruiting)
Study contacts
- Principal investigator: Mustafa Yılmaz — Mersin University
- Study coordinator: Hilmi Bozkurt, Assoc prof
- Email: hilmibozkurt27@gmail.com
- Phone: 0905321780880
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.